Michael K. Templin
Director of Finance/CFO at ABT Molecular Imaging, Inc.
Profile
Michael K.
Templin is currently the Chief Financial Officer & Vice President-Finance at ABT Molecular Imaging, Inc. He previously held the same position at CTI Molecular Imaging, Inc. and worked as an Audit Manager at Coopers & Lybrand LLP.
He received his undergraduate degree and MBA from the University of Tennessee.
Michael K. Templin active positions
| Companies | Position | Start |
|---|---|---|
ABT Molecular Imaging, Inc.
 ABT Molecular Imaging, Inc. BiotechnologyHealth Technology ABT Molecular Imaging, Inc. develops a production platform to generate unit doses of molecular imaging drugs. It markets the BG-75 Biomarker Generator, which produces unit doses of molecular imaging drugs for positron emission tomography at the point of use. The company was founded by Ronald Nutt and Lynda J. Nutt in 2006 and is headquartered in Louisville, TN. | Director of Finance/CFO | 2013-01-31 |
Former positions of Michael K. Templin
| Companies | Position | End |
|---|---|---|
| Coopers & Lybrand LLP | Corporate Officer/Principal | - |
CTI Molecular Imaging, Inc.
 CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN | Director of Finance/CFO | - |
Training of Michael K. Templin
| University of Tennessee | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
CTI Molecular Imaging, Inc.
CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
ABT Molecular Imaging, Inc.
ABT Molecular Imaging, Inc. BiotechnologyHealth Technology ABT Molecular Imaging, Inc. develops a production platform to generate unit doses of molecular imaging drugs. It markets the BG-75 Biomarker Generator, which produces unit doses of molecular imaging drugs for positron emission tomography at the point of use. The company was founded by Ronald Nutt and Lynda J. Nutt in 2006 and is headquartered in Louisville, TN. | Health Technology |
- Stock Market
- Insiders
- Michael K. Templin
